Table 1 Characteristics of all trial participants and prediction model-building cohort.

From: Predicting radiocephalic arteriovenous fistula success with machine learning

Baseline Characteristics

All Trial Participants

Predictive Modeling

N = 914

N = 591

Age (Years)

57 (13)

57 (13)

Sex (Female)

203 (22%)

130 (22%)

Race

White

619 (68%)

382 (65%)

African American

219 (24%)

149 (25%)

Other

76 (8.3%)

60 (10%)

Hispanic

156 (17%)

99 (17%)

BMI

31 [26,37]

31 [26,37]

Smoking Status

Current

131 (14%)

91 (15%)

Former

403 (44%)

257 (43%)

Never

380 (42%)

243 (41%)

Medical History

Diabetes

580 (63%)

382 (65%)

Hypertension

885 (97%)

573 (97%)

Heart Failure

252 (28%)

166 (28%)

Coronary Artery Disease

260 (28%)

172 (29%)

Peripheral Artery Disease

95 (10%)

47 (8.0%)

Cerebrovascular Disease

129 (14%)

79 (13%)

Any Antithrombotic

499 (55%)

336 (57%)

Statin Use

499 (55%)

312 (53%)

Prior Renal Transplant

37 (4.0%)

26 (4.4%)

Prevalent HD

409 (45%)

326 (55%)

Duration of Prior HD (Months)

9 (5,19)

9 (5,19)

Current or Prior CVC

444 (49%)

343 (58%)

Location of AVF

Wrist

669 (73%)

445 (75%)

Forearm

220 (24%)

132 (22%)

Snuffbox

25 (2.7%)

14 (2.4%)

Intraop. Vein Diameter

≥ 4.0 mm

282 (31%)

186 (31%)

3.0–3.9 mm

451 (49%)

296 (50%)

< 3.0 mm

181 (20%)

109 (18%)

Intraop. Artery Diameter

≥ 3.0 mm

433 (48%)

274 (47%)

2.0–2.9 mm

450 (49%)

293 (50%)

< 2.0 mm

28 (3.1%)

22 (3.7%)

Anesthesia

General/Local

205 (22%)

124 (21%)

Regional

709 (78%)

467 (79%)

Site Enrollment Volume

Lower (≤ 20)

316 (35%)

197 (33%)

Mid (21–49)

303 (33%)

181 (31%)

Upper (≥ 50)

295 (32%)

213 (36%)

  1. Data are presented as mean (standard deviation), count (percentage), and median [interquartile range].